Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea.
Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Ann Lab Med. 2017 Nov;37(6):516-521. doi: 10.3343/alm.2017.37.6.516.
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare inherited disorder characterized by infantile-onset macrocephaly, slow neurologic deterioration, and seizures. Mutations in the causative gene, MLC1, are found in approximately 75% of patients and are inherited in an autosomal recessive manner. We analyzed MLC1 mutations in five unrelated Korean patients with MLC.
Direct Sanger sequencing was used to identify MLC1 mutations. A founder effect of the p.Ala275Asp variant was demonstrated by haplotype analysis using single-nucleotide polymorphic (SNP) markers. Multiple ligation-dependent probe amplification (MLPA) and comparative genomic hybridization plus SNP array were used to detect exonic deletions or uniparental disomy (UPD).
The most prevalent pathogenic variant was c.824C>A (p.Ala275Asp) found in 7/10 (70%) alleles. Two pathogenic frameshift variants were found: c.135delC (p.Cys46Alafs12) and c.337_353delinsG (p.Ile113Glyfs4). Haplotype analysis suggested that the Korean patients with MLC harbored a founder mutation in p.Ala275Asp. The p.(Ile113Glyfs*4) was identified in a homozygous state, and a family study revealed that only the mother was heterozygous for this variant. Further analysis of MLPA and SNP arrays for this patient demonstrated loss of heterozygosity of chromosome 22 without any deletion, indicating UPD. The maternal origin of both chromosomes 22 was demonstrated by haplotype analysis.
This study is the first to describe the mutational spectrum of Korean patients with MLC, demonstrating a founder effect of the p.Ala275Asp variant. This study also broadens our understanding of the mutational spectrum of MLC1 by demonstrating a homozygous p.(Ile113Glyfs*4) variant resulting from UPD of chromosome 22.
巨脑白质脑病伴脑下囊肿(MLC)是一种罕见的遗传性疾病,其特征为婴儿期发病的大头畸形、缓慢的神经恶化和癫痫发作。约 75%的患者存在致病基因 MLC1 的突变,且该突变以常染色体隐性遗传方式遗传。我们分析了 5 例韩国 MLC 患者的 MLC1 突变。
采用直接 Sanger 测序法鉴定 MLC1 突变。通过单核苷酸多态性(SNP)标记的单体型分析,证实了 p.Ala275Asp 变异的起源效应。采用多重连接依赖性探针扩增(MLPA)和比较基因组杂交加 SNP 芯片分析,检测外显子缺失或单亲二体性(UPD)。
最常见的致病性变异是 c.824C>A(p.Ala275Asp),在 7/10(70%)等位基因中发现。发现了 2 种致病性移码变异:c.135delC(p.Cys46Alafs12)和 c.337_353delinsG(p.Ile113Glyfs4)。单体型分析提示,韩国 MLC 患者携带 p.Ala275Asp 突变的起源突变。p.(Ile113Glyfs*4) 以纯合状态存在,家系研究显示,只有母亲为该变异的杂合子。对该患者进行 MLPA 和 SNP 芯片的进一步分析显示,22 号染色体杂合性丢失,无缺失,提示 UPD。通过单体型分析证实,22 号染色体的母源来源。
本研究首次描述了韩国 MLC 患者的突变谱,证实了 p.Ala275Asp 变异的起源效应。本研究还通过证明源自 22 号染色体 UPD 的纯合 p.(Ile113Glyfs*4) 变异,拓宽了我们对 MLC1 突变谱的认识。